Vera Therapeutics, Inc. (VERA) Misses Q2 EPS by 6c
Tweet
Share
E-mailGet Alerts VERA Hot Sheet
Price: $35.66 +4.18%
EPS Growth %: -27.8%
Financial Fact:
Engineering and software development: 322.64K
Today's EPS Names:
RCBC, GASS, YSG, More
EPS Growth %: -27.8%
Financial Fact:
Engineering and software development: 322.64K
Today's EPS Names:
RCBC, GASS, YSG, More
Join SI Premium – FREE
Vera Therapeutics, Inc. (NASDAQ: VERA) reported Q2 EPS of ($0.62), $0.06 worse than the analyst estimate of ($0.56).
For earnings history and earnings-related data on Vera Therapeutics, Inc. (VERA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Methode Electronics (MEI) Tops Q1 EPS by 2c; offers guidance
- Five Below (FIVE) Tops Q2 EPS by 35c, Beats on Revenue; Offers Q3 Revenue Guidance
- Five Below raises full-year outlook after strong second-quarter sales growth
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
